| - GRCh37:
- Chr11:61717400
- GRCh38:
- Chr11:61949928
| BEST1 | | Vitelliform macular dystrophy 2, Retinitis Pigmentosa, Recessive, Autosomal dominant vitreoretinochoroidopathy
| Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61717508
- GRCh38:
- Chr11:61950036
| BEST1 | | Retinitis Pigmentosa, Recessive, Autosomal dominant vitreoretinochoroidopathy, Vitelliform macular dystrophy 2
| Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61717563
- GRCh38:
- Chr11:61950091
| BEST1 | | Retinitis Pigmentosa, Recessive, Vitelliform macular dystrophy 2, Autosomal dominant vitreoretinochoroidopathy
| Likely benign (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61717607
- GRCh38:
- Chr11:61950135
| BEST1 | | Vitelliform macular dystrophy 2, not provided, Retinitis Pigmentosa, Recessive, Autosomal dominant vitreoretinochoroidopathy | Benign (Jul 7, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61717715
- GRCh38:
- Chr11:61950243
| BEST1 | | Autosomal dominant vitreoretinochoroidopathy, Vitelliform macular dystrophy 2, Retinitis Pigmentosa, Recessive, not provided | Benign (Jun 26, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61717811
- GRCh38:
- Chr11:61950339
| BEST1 | | Vitelliform macular dystrophy 2, Retinitis Pigmentosa, Recessive, Autosomal dominant vitreoretinochoroidopathy
| Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61717815
- GRCh38:
- Chr11:61950343
| BEST1 | | Autosomal dominant vitreoretinochoroidopathy, Vitelliform macular dystrophy 2, Retinitis Pigmentosa, Recessive
| Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61717870
- GRCh38:
- Chr11:61950398
| BEST1 | | Retinitis pigmentosa, Vitelliform macular dystrophy 2, Autosomal dominant vitreoretinochoroidopathy
| Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61717900
- GRCh38:
- Chr11:61950428
| BEST1 | | Autosomal recessive bestrophinopathy | Likely pathogenic (Jan 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61717904
- GRCh38:
- Chr11:61950432
| BEST1 | | not provided | Uncertain significance (Aug 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61718036
- GRCh38:
- Chr11:61950564
| BEST1 | | not provided | Benign (Jun 26, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61718173
- GRCh38:
- Chr11:61950701
| BEST1 | | not provided | Likely benign (Jul 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61718228
- GRCh38:
- Chr11:61950756
| BEST1 | | not provided | Likely benign (Jul 14, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719026
- GRCh38:
- Chr11:61951554
| BEST1 | | not provided | Benign (Jul 9, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719070
- GRCh38:
- Chr11:61951598
| BEST1 | | not provided | Benign (Jul 10, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719279
- GRCh38:
- Chr11:61951807
| BEST1 | M1V | not provided | Pathogenic (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719283
- GRCh38:
- Chr11:61951811
| BEST1 | T2S | Retinal dystrophy, not provided | Pathogenic/Likely pathogenic (Oct 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719286
- GRCh38:
- Chr11:61951814
| BEST1 | I3N | not provided | Likely pathogenic (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719289
- GRCh38:
- Chr11:61951817
| BEST1 | T4I | not provided | Pathogenic (Aug 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719291
- GRCh38:
- Chr11:61951819
| BEST1 | Y5N | not provided | Uncertain significance (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719294
- GRCh38:
- Chr11:61951822
| BEST1 | T6A | not provided, Retinal dystrophy | Pathogenic/Likely pathogenic (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719294
- GRCh38:
- Chr11:61951822
| BEST1 | T6P | not provided, Vitelliform macular dystrophy 2 | Pathogenic (Aug 1, 2007) | no assertion criteria provided |
| - GRCh37:
- Chr11:61719295
- GRCh38:
- Chr11:61951823
| BEST1 | T6K | Vitelliform macular dystrophy 2 | Likely pathogenic (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719295
- GRCh38:
- Chr11:61951823
| BEST1 | T6R | not provided | Pathogenic/Likely pathogenic (Nov 10, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719298
- GRCh38:
- Chr11:61951826
| BEST1 | S7N | not provided | Uncertain significance (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719303
- GRCh38:
- Chr11:61951831
| BEST1 | V9L | not provided | Pathogenic (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719303
- GRCh38:
- Chr11:61951831
| BEST1 | V9M | Vitelliform macular dystrophy 2 | Pathogenic (Sep 1, 1998) | no assertion criteria provided |
| - GRCh37:
- Chr11:61719304
- GRCh38:
- Chr11:61951832
| BEST1 | V9G | Vitelliform macular dystrophy 2 | Likely pathogenic (Sep 11, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719304
- GRCh38:
- Chr11:61951832
| BEST1 | V9A | not provided | not provided | no assertion provided |
| - GRCh37:
- Chr11:61719306
- GRCh38:
- Chr11:61951834
| BEST1 | A10T | Retinal dystrophy, not provided | Pathogenic (Aug 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719307
- GRCh38:
- Chr11:61951835
| BEST1 | A10V | not provided | Pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719310
- GRCh38:
- Chr11:61951838
| BEST1 | N11S | not provided | Likely pathogenic (Aug 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719310
- GRCh38:
- Chr11:61951838
| BEST1 | N11I | not provided | not provided | no assertion provided |
| - GRCh37:
- Chr11:61719311
- GRCh38:
- Chr11:61951839
| BEST1 | N11K | not provided | Conflicting interpretations of pathogenicity (Oct 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61719311
- GRCh38:
- Chr11:61951839
| BEST1 | | not provided | Likely benign (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719313
- GRCh38:
- Chr11:61951841
| BEST1 | A12V | not provided | Uncertain significance (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719313
- GRCh38:
- Chr11:61951841
| BEST1 | A12G | Vitelliform macular dystrophy 2, Retinal dystrophy | Uncertain significance (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719315
- GRCh38:
- Chr11:61951843
| BEST1 | R13G | not provided, Isolated macular dystrophy | Pathogenic/Likely pathogenic (Jan 9, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719315
- GRCh38:
- Chr11:61951843
| BEST1 | R13C | Vitelliform macular dystrophy 2, Retinal dystrophy, not provided
| Conflicting interpretations of pathogenicity (Oct 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61719316
- GRCh38:
- Chr11:61951844
| BEST1 | R13P | not provided | Likely pathogenic (Jan 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719316
- GRCh38:
- Chr11:61951844
| BEST1 | R13H | Retinal dystrophy, not provided | Pathogenic/Likely pathogenic (Jul 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719319
- GRCh38:
- Chr11:61951847
| BEST1 | L14S | not provided | Uncertain significance (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719322
- GRCh38:
- Chr11:61951850
| BEST1 | G15D | not provided | Pathogenic (Sep 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719325
- GRCh38:
- Chr11:61951853
| BEST1 | S16Y | not provided | Pathogenic (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719325
- GRCh38:
- Chr11:61951853
| BEST1 | S16F | not provided | Pathogenic (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719326-61719328
- GRCh38:
- Chr11:61951854-61951856
| BEST1 | F17del | not provided | Uncertain significance (Jun 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719327
- GRCh38:
- Chr11:61951855
| BEST1 | F17I | not provided | Likely pathogenic (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719328
- GRCh38:
- Chr11:61951856
| BEST1 | F17Y | not provided | Likely pathogenic (Dec 1, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719328
- GRCh38:
- Chr11:61951856
| BEST1 | F17C | not provided | not provided | no assertion provided |
| - GRCh37:
- Chr11:61719329
- GRCh38:
- Chr11:61951857
| BEST1 | F17L | not provided | Uncertain significance (Jul 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719333
- GRCh38:
- Chr11:61951861
| BEST1 | R19C | not provided | Conflicting interpretations of pathogenicity (Mar 11, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61719334
- GRCh38:
- Chr11:61951862
| BEST1 | R19H | not provided | Likely pathogenic (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719336
- GRCh38:
- Chr11:61951864
| BEST1 | L20V | Vitelliform macular dystrophy 2 | Pathogenic (Apr 1, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr11:61719338
- GRCh38:
- Chr11:61951866
| BEST1 | | not provided | Likely benign (Mar 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719339
- GRCh38:
- Chr11:61951867
| BEST1 | L21V | not provided | Likely pathogenic (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719340
- GRCh38:
- Chr11:61951868
| BEST1 | L21R | not provided | Pathogenic (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719340
- GRCh38:
- Chr11:61951868
| BEST1 | L21Q | not provided | Likely pathogenic (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719344
- GRCh38:
- Chr11:61951872
| BEST1 | | not provided | Likely benign (Jun 12, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719347
- GRCh38:
- Chr11:61951875
| BEST1 | | not provided | Likely benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719348
- GRCh38:
- Chr11:61951876
| BEST1 | W24R | not provided | Likely pathogenic (Apr 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719350
- GRCh38:
- Chr11:61951878
| BEST1 | W24* | not provided | Pathogenic (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719350
- GRCh38:
- Chr11:61951878
| BEST1 | W24C | not provided | not provided | no assertion provided |
| - GRCh37:
- Chr11:61719351
- GRCh38:
- Chr11:61951879
| BEST1 | R25W | not provided, Vitelliform macular dystrophy 2 | Pathogenic/Likely pathogenic (Oct 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719352
- GRCh38:
- Chr11:61951880
| BEST1 | R25Q | not provided, Autosomal recessive bestrophinopathy | Pathogenic (Feb 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719354
- GRCh38:
- Chr11:61951882
| BEST1 | G26S | not provided | Likely pathogenic (Sep 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719355
- GRCh38:
- Chr11:61951883
| BEST1 | G26D | Retinal dystrophy | Uncertain significance (Jan 27, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719356
- GRCh38:
- Chr11:61951884
| BEST1 | | not provided | Likely benign (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719357
- GRCh38:
- Chr11:61951885
| BEST1 | S27G | not provided | Likely pathogenic (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719358
- GRCh38:
- Chr11:61951886
| BEST1 | S27N | not provided | Likely pathogenic (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719359
- GRCh38:
- Chr11:61951887
| BEST1 | S27R | not provided | not provided | no assertion provided |
| - GRCh37:
- Chr11:61719362
- GRCh38:
- Chr11:61951890
| BEST1 | | not provided | Likely benign (Dec 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719363
- GRCh38:
- Chr11:61951891
| BEST1 | Y29H | not provided | Pathogenic (Nov 1, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719364
- GRCh38:
- Chr11:61951892
| BEST1 | Y29C | Vitelliform macular dystrophy 2, not provided | Likely pathogenic (Jul 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719365
- GRCh38:
- Chr11:61951893
| BEST1 | | not provided | not provided | no assertion provided |
| - GRCh37:
- Chr11:61719365
- GRCh38:
- Chr11:61951893
| BEST1 | Y29* | not provided | Pathogenic (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719367
- GRCh38:
- Chr11:61951895
| BEST1 | K30R | Retinal dystrophy, not provided, Vitelliform macular dystrophy 2
| Conflicting interpretations of pathogenicity (Sep 29, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61719371
- GRCh38:
- Chr11:61951899
| BEST1 | | not provided | Likely benign (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719373
- GRCh38:
- Chr11:61951901
| BEST1 | L32P | not provided | Likely pathogenic (Sep 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719375
- GRCh38:
- Chr11:61951903
| BEST1 | Y33D | Retinal dystrophy | Uncertain significance (Jul 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719375
- GRCh38:
- Chr11:61951903
| BEST1 | Y33H | Retinal dystrophy, not provided | Conflicting interpretations of pathogenicity (May 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61719377
- GRCh38:
- Chr11:61951905
| BEST1 | | not provided | Likely benign (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719380
- GRCh38:
- Chr11:61951908
| BEST1 | | not provided | Pathogenic (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719381
- GRCh38:
- Chr11:61951909
| BEST1 | E35K | Autosomal recessive bestrophinopathy, BEST1-related condition, not provided
| Pathogenic/Likely pathogenic (Jul 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719383
- GRCh38:
- Chr11:61951911
| BEST1 | E35D | Autosomal recessive bestrophinopathy | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719387-61719388
- GRCh38:
- Chr11:61951915-61951916
| BEST1 | L37P | not provided | Uncertain significance (Aug 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719387
- GRCh38:
- Chr11:61951915
| BEST1 | | not specified, not provided, Retinitis pigmentosa, Autosomal dominant vitreoretinochoroidopathy, Retinitis pigmentosa 50, Autosomal recessive bestrophinopathy, Vitelliform macular dystrophy 2 | Benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719391
- GRCh38:
- Chr11:61951919
| BEST1 | I38S | not provided | Uncertain significance (Mar 15, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719395
- GRCh38:
- Chr11:61951923
| BEST1 | | not provided | Likely benign (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719396-61719397
- GRCh38:
- Chr11:61951924-61951925
| BEST1 | L41fs | not provided | Pathogenic (Aug 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719400
- GRCh38:
- Chr11:61951928
| BEST1 | L41P | not provided | Pathogenic (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719411
- GRCh38:
- Chr11:61951939
| BEST1 | I45V | not provided | Uncertain significance (Jul 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719413
- GRCh38:
- Chr11:61951941
| BEST1 | | not provided | Likely benign (Mar 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719415
- GRCh38:
- Chr11:61951943
| BEST1 | I46T | not provided | Uncertain significance (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719417
- GRCh38:
- Chr11:61951945
| BEST1 | R47C | Retinitis pigmentosa, Autosomal dominant vitreoretinochoroidopathy, not provided, Vitelliform macular dystrophy 2 | Conflicting interpretations of pathogenicity (Jul 19, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:61719418
- GRCh38:
- Chr11:61951946
| BEST1 | R47L | not provided | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719418
- GRCh38:
- Chr11:61951946
| BEST1 | R47H | not provided, Vitelliform macular dystrophy 2 | Pathogenic/Likely pathogenic (Feb 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:61719419
- GRCh38:
- Chr11:61951947
| BEST1 | | not provided | Likely benign (Jan 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719428
- GRCh38:
- Chr11:61951956
| BEST1 | | not provided | Likely benign (Dec 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719430
- GRCh38:
- Chr11:61951958
| BEST1 | R51K | not provided | Uncertain significance (Jan 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:61719436
- GRCh38:
- Chr11:61951964
| BEST1 | | Retinitis pigmentosa, Vitelliform macular dystrophy 2, not provided, Autosomal dominant vitreoretinochoroidopathy | Conflicting interpretations of pathogenicity (Sep 19, 2022) | criteria provided, conflicting interpretations |